Mnemo Therapeutics and Institut Curie announce two key publications in Science Immunology highlighting novel approach to identify unknown, therapeutically relevant cancer-specific targets
Two studies published in Science Immunology reveal that TE-exon splicing junctions can differentiate tumors from healthy tissue, offering a potential solution to the field of immuno-oncology. The research identifies novel recurrent, cancer-specific targets and validates Mnemo's antigen discovery platform.